{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:09:02Z","timestamp":1792084142898,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Nancy Taylor Foundation for Chronic Diseases, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.cyto.2011.04.001","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T16:36:30Z","timestamp":1304699790000},"page":"157-164","source":"Crossref","is-referenced-by-count":100,"title":["Cytokine profiles in localized scleroderma and relationship to clinical features"],"prefix":"10.1016","volume":"55","author":[{"given":"Katherine","family":"Kurzinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0005","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.cyto.2011.04.001_b0010","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cyto.2011.04.001_b0015","series-title":"Lever\u2019s histopathology of the skin","author":"Lever","year":"1997"},{"key":"10.1016\/j.cyto.2011.04.001_b0020","series-title":"Pathology of the skin: with clinical correlations","author":"McKee","year":"1996"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/BOR.0b013e328309a5eb","article-title":"New developments in localized scleroderma","volume":"20","author":"Zulian","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199806000-00003","article-title":"Histopathologic differentiation between localized and systemic scleroderma","volume":"20","author":"Torres","year":"1998","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0045","first-page":"328","article-title":"Elevated serum levels of interleukin-4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.cyto.2011.04.001_b0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann Intern Med"},{"issue":"63","key":"10.1016\/j.cyto.2011.04.001_b0060","first-page":"206","article-title":"Interleukin-2 and interleukin-6 in serum as markers of disease progression in systemic sclerosis","volume":"11","author":"Lis","year":"2001","journal-title":"Pol Merkuriusz Lek"},{"issue":"3\u20134","key":"10.1016\/j.cyto.2011.04.001_b0065","first-page":"251","article-title":"The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis","volume":"36","author":"Alecu","year":"1998","journal-title":"Rom J Intern Med"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01262331","article-title":"Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma","volume":"287","author":"Ihn","year":"1995","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.001_b0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jlb.47.4.312","article-title":"Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth","volume":"47","author":"Thornton","year":"1990","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000163881","article-title":"In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts","volume":"62","author":"Cho","year":"1994","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.001_b0085","first-page":"663","article-title":"Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0090","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.142.5.1542","article-title":"IL-6\/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans","volume":"142","author":"Jablons","year":"1989","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000071783","article-title":"Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma","volume":"207","author":"Hasegawa","year":"2003","journal-title":"Dermatology"},{"issue":"10","key":"10.1016\/j.cyto.2011.04.001_b0100","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/intimm\/10.10.1421","article-title":"IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts","volume":"10","author":"Doucet","year":"1998","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0105","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1073\/pnas.052709999","article-title":"Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts","volume":"99","author":"Kodera","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.cyto.2011.04.001_b0110","first-page":"823","article-title":"Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents","volume":"37","author":"Fertin","year":"1991","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.cyto.2011.04.001_b0115","first-page":"181","article-title":"Interleukin-4; structure, function and clinical aspects","volume":"4","author":"Peyron","year":"1994","journal-title":"Eur J Dermatol"},{"issue":"Pt 3","key":"10.1016\/j.cyto.2011.04.001_b0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3070673","article-title":"Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4","volume":"307","author":"Wegrowski","year":"1995","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/rheumatology\/34.2.101","article-title":"The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation","volume":"34","author":"Shingu","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.001_b0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","article-title":"Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma","volume":"31","author":"Sato","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)35380-7","article-title":"Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts","volume":"292","author":"Oriente","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/BOR.0b013e328304b6b5","article-title":"IL-17 and the Th17 lineage in systemic lupus erythematosus","volume":"20","author":"Garrett-Sinha","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2007.04.005","article-title":"Differentiation and function of Th17 T cells","volume":"19","author":"Stockinger","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1016\/j.cyto.2011.04.001_b0155","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2011.04.001_b0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2011.04.001_b0165","first-page":"S839","article-title":"Th1 and Th17 cytokine signatures in early pediatric localized scleroderma","volume":"62","author":"Torok","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.cyto.2011.04.001_b0170","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0175","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.cyto.2011.04.001_b0180","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.cyto.2011.04.001_b0185","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4","author":"Naka","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000236334","article-title":"In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease","volume":"99","author":"Romero","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0195","first-page":"296","article-title":"Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts","volume":"25","author":"Kadono","year":"1998","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0200","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","article-title":"Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts","volume":"247","author":"Varga","year":"1987","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.cyto.2011.04.001_b0210","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/j.1460-2075.1987.tb02449.x","article-title":"Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor","volume":"6","author":"Edwards","year":"1987","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud\u2019s phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0220","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0225","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma \u2013 where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-1811(99)00008-0","article-title":"Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma","volume":"21","author":"Querfeld","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cyto.2011.04.001_b0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-5-22","article-title":"Increased serum levels of TGFbeta1 in children with localized scleroderma","volume":"5","author":"Uziel","year":"2007","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/1043-4666(89)91043-0","article-title":"Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF","volume":"1","author":"Matsushima","year":"1989","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0245","first-page":"31","article-title":"Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor","volume":"68","author":"Larsen","year":"1989","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archderm.1993.01680230073008","article-title":"Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders","volume":"129","author":"Reitamo","year":"1993","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.cyto.2011.04.001_b0255","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archderm.1994.01690100117021","article-title":"Demonstration of interleukin 8 in serum samples of patients with localized scleroderma","volume":"130","author":"Ihn","year":"1994","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.cyto.2011.04.001_b0260","first-page":"471","article-title":"The soluble interleukin-2 receptor as a marker for human neoplasia and immune status","volume":"3","author":"Zerler","year":"1991","journal-title":"Cancer Cells"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0265","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/37.3.304","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin","volume":"37","author":"Sondergaard","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-1229(90)90147-I","article-title":"Soluble and cellular markers of immune activation in patients with systemic sclerosis","volume":"56","author":"Degiannis","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"issue":"11\u201312","key":"10.1016\/j.cyto.2011.04.001_b0275","first-page":"532","article-title":"Soluble receptors of cytokines in sera of patients with systemic sclerosis\u2013clinical correlation","volume":"56","author":"Lis","year":"2003","journal-title":"Wiad Lek"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.001_b0280","first-page":"646","article-title":"Soluble serum interleukin 2 receptors in patients with systemic sclerosis","volume":"23","author":"Steen","year":"1996","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.001_b0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.1996.tb06313.x","article-title":"Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma","volume":"134","author":"Ihn","year":"1996","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.001_b0290","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.1780370618","article-title":"Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma","volume":"37","author":"Uziel","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.cyto.2011.04.001_b0295","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.148.7.2175","article-title":"Human soluble IL-6 receptor: its detection and enhanced release by HIV infection","volume":"148","author":"Honda","year":"1992","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.001_b0300","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","article-title":"Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.1995.tb03672.x","article-title":"Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases","volume":"100","author":"Yokoyama","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2011.04.001_b0310","first-page":"2069","article-title":"Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies","volume":"24","author":"Uson","year":"1997","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.001_b0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0192-0561(95)00106-9","article-title":"IL-6-soluble IL-6 receptor complex inhibits the proliferation of dermal fibroblasts","volume":"18","author":"Mihara","year":"1996","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.001_b0320","first-page":"308","article-title":"Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis","volume":"25","author":"Hasegawa","year":"1998","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.cyto.2011.04.001_b0325","first-page":"1917","article-title":"Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma","volume":"27","author":"Nagaoka","year":"2000","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.001_b0330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.cyto.2011.04.001_b0335","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.cyto.2011.04.001_b0340","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:04:39Z","timestamp":1741176279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1043466611001025"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.04.001","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}